CARD for Community Pharmacy Vaccinations
Launched by UNIVERSITY OF TORONTO · Oct 19, 2023
Trial Information
Current as of August 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called CARD for Community Pharmacy Vaccinations, is looking to improve how vaccinations are given in community pharmacies. The goal is to see how using a special program called CARD can help both people getting vaccinated and the pharmacy staff who assist them. Researchers want to understand the effects on vaccine clients—those receiving shots—and on the pharmacy team involved in the process.
To participate, individuals must be receiving a vaccine at a community pharmacy that is taking part in the study. This includes people of all ages and genders who can understand and read English. However, if someone cannot read or understand English, they won't be able to join. Participants can expect to be part of a system that aims to make vaccinations more comfortable and effective. It's important to know that this trial is not yet recruiting participants, so there's still time to learn more about it before it starts.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • vaccine clients being vaccinated in community pharmacies participating in the project
- • pharmacy staff in community pharmacies participating in the project
- Exclusion Criteria:
- • unable to understand and read English
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
Patients applied
Trial Officials
Anna Taddio, PhD
Principal Investigator
University of Toronto
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported